The treatment of skin immune diseases is one of the most successful cases in immunological translational medicine. With the application of biological agents, more and more patients are achieving the treatment goal of complete or almost complete clearance of skin lesions and itching. We still have many questions regarding the pharmaceutical mechanisms of biological agents, rational and safe use of drugs, long-term patient management, and early intervention. In order to promote the development of skin immune diseases, psoriasis, urticaria and other fields, improve the level of precision diagnosis and treatment, use biological agents reasonably and safely, manage chronic diseases throughout the process, and reduce the disease burden of patients, Yun Shalong, an expert in the standardized diagnosis and treatment of immune allergic diseases, hosted by the Chengdu High tech Medical Association, held a series of academic conferences on April 24, 2024 online. The conference invited industry experts to give wonderful lectures on relevant topics and had lively discussions. The attending representatives expressed great benefits and hoped to participate in similar conferences more in the future.